COMPARATIVE ACTIVITIES OF 8 QUINOLONES AGAINST MEMBERS OF THE BACTEROIDES-FRAGILIS GROUP

被引:14
作者
BOROBIO, MV
CONEJO, MD
RAMIREZ, E
SUAREZ, AI
PEREA, EJ
机构
关键词
D O I
10.1128/AAC.38.6.1442
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro activities of five new quinolones (clinafloxacin [CI-960 or PD-127391], BAY Y 3118, E-4868, E-5065, and E-5068) against 100 Bacteroides fragilis group bacterial isolates were compared with those of ciprofloxacin, ofloxacin, and sparfloxacin. Overall, E-5068 was the most active in vitro (MIC for 90% of isolates tested [MIC(90)], 0.25 mu g/ml); this was followed by clinafloxacin and BAY Y 3118 (MIC(90), 0.5 mu g/ml). Ciprofloxacin, sparfloxacin, and ofloxacin were the least active (MIC(90)s, 64, 16, and 16 mu g/ml, respectively). B. fragilis and Bacteroides caccae were more susceptible than the other members of the B. fragilis group to all of the quinolones tested.
引用
收藏
页码:1442 / 1445
页数:4
相关论文
共 19 条
[1]   SUSCEPTIBILITIES OF 394 BACTEROIDES-FRAGILIS, NON-B-FRAGILIS GROUP BACTEROIDES SPECIES, AND FUSOBACTERIUM SPECIES TO NEWER ANTIMICROBIAL AGENTS [J].
APPELBAUM, PC ;
SPANGLER, SK ;
JACOBS, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (06) :1214-1218
[2]   INVITRO ACTIVITY OF E-4868, A NEW TRIFLUOROQUINOLONE, COMPARED TO 6 SIMILAR COMPOUNDS [J].
BARRETT, MS ;
JONES, RN ;
ERWIN, ME .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (02) :134-141
[3]   INVITRO ACTIVITIES OF SPARFLOXACIN, TOSUFLOXACIN, CIPROFLOXACIN, AND FLEROXACIN [J].
BARRY, AL ;
FUCHS, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (05) :955-960
[4]   METHODS FOR TESTING THE SUSCEPTIBILITY OF ANAEROBIC-BACTERIA TO 2 FLUOROQUINOLONE COMPOUNDS, PD-131628 AND CLINAFLOXACIN [J].
BARRY, AL ;
FUCHS, PC ;
CITRON, DM ;
ALLEN, SD ;
WEXLER, HM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (06) :893-900
[5]   COMPARATIVE INVITRO ACTIVITIES OF THE NEW QUINOLONE, BAY-Y-3118, AND CIPROFLOXACIN, SPARFLOXACIN, TOSUFLOXACIN, CI-960 AND CI-990 [J].
BAUERNFEIND, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (04) :505-522
[6]   EFFECT OF INOCULUM, PH, AND MEDIUM ON THE ACTIVITY OF CIPROFLOXACIN AGAINST ANAEROBIC-BACTERIA [J].
BOROBIO, MV ;
PEREA, EJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :342-343
[7]   SURVEY OF BACTEROIDES-FRAGILIS GROUP SUSCEPTIBILITY PATTERNS IN CANADA [J].
BOURGAULT, AM ;
LAMOTHE, F ;
HOBAN, DJ ;
DALTON, MT ;
KIBSEY, PC ;
HARDING, G ;
SMITH, JA ;
LOW, DE ;
GILBERT, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (02) :343-347
[8]  
Chen J. -S., 1977, ANAEROBE LAB MANUAL, VFourth
[9]   MULTICENTER EVALUATION OF THE INVITRO ACTIVITIES OF 3 NEW QUINOLONES, SPARFLOXACIN, CI-960, AND PD-131,628, COMPARED WITH THE ACTIVITY OF CIPROFLOXACIN AGAINST 5,252 CLINICAL BACTERIAL ISOLATES [J].
FUCHS, PC ;
BARRY, AL ;
PFALLER, MA ;
ALLEN, SD ;
GERLACH, EH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :764-766
[10]  
GARCIARODRIGUEZ JA, 1993, 6TH EUR C CLIN MICR